Miyagi Children's Hospital

Miyagi 989-3126

0 studies enrolling now · 2 studies all time

What they study most

Duchenne Muscular Dystrophy, Muscular Atrophy, Spinal

Studies at this site

• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants — Completed
• Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy — Completed